Drinker Biddle & Reath Llp
Recent News About Drinker Biddle & Reath Llp
-
AI and Bias in Hiring Promotion Practices on December 13, 2023
Employers within the U.S. are slowly implementing artificial intelligence (AI) tools to help make employment decisions. -
Trade Secrets: Recent Developments and Hot Topics on December 6, 2023
Trade secret litigation has been on the rise in recent years. -
It's a Wrap! Update on 2023 Immigration Trends and 2024 Outlook on December 5, 2023
Please join Faegre Drinker for the last webinar in our 2023 Immigration and Global Mobility series. -
Minnesota Lobbying and Campaign Finance Update on November 29, 2023
Last session the Minnesota Legislature passed a number of changes impacting state and local government lobbying and political activity. -
Is the EU Sleepwalking into a U.S.-Style Litigation System? on November 1
A perfect storm of regulatory activity is progressing in the EU following the creation of the Collective Redress Directive. -
How International Organizations Effectively Implement Employment Policies Across Jurisdictions on October 24, 2023
Many multinational companies want to implement global employment policies that are both legally compliant and reflective of company culture. -
M&A Conference – Des Moines on October 3, 2023
Join us as nationally recognized leaders discuss everything M&A — from today’s market trends to distressed deals to changes in law and regulations that will impact how to best shepherd deals to close. -
Assessing the Aftermath: The Impact of the Supreme Court’s Harvard/UNC Decision on the Nonprofit Sector on September 27, 2023
It has been almost three months since the Supreme Court decided Students for Fair Admissions, effectively striking down race-conscious admissions programs in higher education. -
FAEGRE DRINKER BIDDLE & REATH LLP: Fraud and Compliance Risks Facing Health Care Providers Under the COVID-19 Provider Relief Fund and Reimbursement Programs
There are key provisions within the CARES Act and other relief programs that support American families, workers and the heroic healthcare providers during this pandemic. -
FAEGRE DRINKER BIDDLE & REATH LLP: Structuring a Stock Acquisition: Due Diligence, Key Deal Terms, Shareholder Consent, and Other Hurdles
Faegre Drinker Biddle & Reath LLP issued the following announcement on.Partner Keith Radtke is giving a CLE webinar on “Structuring a Stock Acquisition: Due Diligence, Key Deal Terms, Shareholder Consent, and Other Hurdles” on June 3, 2020, at 1:00 p.m. -
FAEGRE DRINKER BIDDLE & REATH LLP: Faegre Drinker Insights Webinar with U.S. Senate Commerce Committee Chairman Roger Wicker
Faegre Drinker invites you to participate in an interactive webinar discussion with U.S. Senator Roger Wicker (MS) on the impact of the COVID-19 pandemic on the American economy and what policies he is prioritizing as the country looks to reopen. -
FAEGRE DRINKER BIDDLE & REATH LLP: 3 Estate and Gift Planning Tips During Uncertain Times
As the COVID-19 pandemic changes financial and life circumstances, here are three estate and gift planning ideas that individuals might want to consider during these uncertain times. -
FAEGRE DRINKER BIDDLE & REATH LLP: Standards of Identity and the Quest to Define “Meat” and “Dairy”
Counsel Alyssa Rebensdorf will moderate a panel on the FDA’s Nutrition Innovation Strategy’s modernization of its Standards of Identity in light of the latest nutritional science and marketing trends. -
Judge in landmark $8 billion Risperdal case cuts punitive damages award down to $6.8 million
PHILADELPHIA – After a Philadelphia jury rendered a staggering $8 billion punitive damages verdict at the end of a recent trial surrounding anti-psychotic drug Risperdal in October, the judge who presided over the trial reduced the verdict to $6.8 million on Friday. -
Facing 12,000 lawsuits, J&J has expert testify that there is no link between talc and ovarian cancer
TRENTON, N.J. – The fate of about 12,000 lawsuits claiming Johnson & Johnson’s talc-containing baby powder causes women to develop both ovarian cancer and mesothelioma, will be decided after eight days of expert witness testimony in a New Jersey federal court. -
Janssen win in Philly Risperdal case overturned by appeals court
HARRISBURG – The Superior Court of Pennsylvania has reinstated a Risperdal lawsuit which was thrown out after 11 days of trial proceedings in a Philadelphia court in December 2016 and said its original granting of nonsuit was improper. -
IL Supreme Court: No actual harm needed to sue businesses for scanning fingerprints, other biometric IDs
The Illinois Supreme Court says an Illinois privacy law doesn’t require plaintiffs to prove they were actually harmed before suing businesses and others who scan and store their fingerprints or other so-called biometric identifiers. And the decision will give a green light to dozens of class action lawsuits already pending against businesses of all sizes in the state’s courts, with even more likely to follow. -
Law prof: Trump's lawless behavior with fiduciary rule undermines process
Mercer Bullard, a University of Mississippi law professor and founder of Fund Democracy, a group that advocates for mutual fund shareholders, is puzzled by the U.S. Department of Labor’s 60-day delay, arguing the rule had one of the most thorough vettings. -
Trump's decision to delay fiduciary rule might improve final version
Uday Singh, a partner in the financial institutions practice of A.T. Kearney, a global strategy and management consulting firm, argues the 60-day holdup already has proven somewhat beneficial, in that new information has emerged.